Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)

Active
Yes
Status
Posted
Published Date
June 15th, 2023
Close Date
September 7th, 2026
Opportunity No.
PAR-23-194

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) has posted a grant opportunity titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)". This grant aims to support doctoral candidates from various academic disciplines for up to two years to complete their doctoral dissertation research project. The research projects should align with NIDA funding priorities and the NIDA Strategic Plan. The goal of this award is to enhance the pool of highly talented researchers in the field of substance use/substance use disorder (SU(D)) research. The NIH encourages applications from individuals who can contribute to diversifying the research workforce. The grant does not require cost sharing or matching. The eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-U.S. components of U.S. Organizations are not eligible to apply. The grant opportunity will close on September 7, 2026. For more information and to apply, visit the following link: http://grants.nih.gov/grants/guide/pa-files/PAR-23-194.html. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

Description

The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (https://www.drugabuse.gov/funding/funding-priorities) or within the NIDA Strategic Plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers. Applications are particularly encouraged from those who can contribute to diversifying the research workforce as described in the Notice of NIH's Interest in Diversity (NOT-OD-20-031).

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)". This grant aims to support clinical research projects that focus on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD) and fundamental brain function relevant to substance use. The grant utilizes a R61/R33 Phased Innovation Award mechanism and is particularly designed to support exploratory and developmental projects that require budgets exceeding those allowed for the R21 mechanism. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for this grant opportunity is May 7, 2026. For more information and to apply, please visit the following link: [Exploratory Clinical Neuroscience Research on Substance Use Disorders Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-157.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)". This grant aims to support clinical research projects that are exploratory and developmental in nature, focusing on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD). The grant is particularly designed to support projects that require budgets exceeding those allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)). The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The opportunity is posted under the discretionary category and falls under CFDA number 93.279. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), non-domestic (non-U.S.) entities (Foreign Organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The opportunity will close on May 7, 2026, and the last updated date was on June 7, 2023. For more information and to apply, please visit the following link: [Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)](http://grants.nih.gov/grants/guide/pa-files/PAR-23-158.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research. This grant opportunity aims to support intensive supervised research training and career development experiences for clinician scientists (Scholars) in the field of substance use and substance use disorder research. The program is designed to help Scholars achieve research independence in this area. The maximum award ceiling for this grant is $750,000. The deadline for applications is November 13, 2026. For more information and to apply, please visit the following link: [NIDA Mentored Clinical Scientist Development Program Award](http://grants.nih.gov/grants/guide/pa-files/PAR-24-089.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)". This grant aims to support translational research in epidemiology, services, and prevention to alleviate the impact of substance use on public health. The grant seeks applications that begin with a planning phase and have the potential for transformative findings through innovative translational research. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for applications is December 14, 2026. For more information and to apply, visit the following link: [Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-24-062.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.